Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/4998
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Some, Fatuma | - |
dc.contributor.author | Koech, Mathew | - |
dc.contributor.author | Chesire, Emily | - |
dc.contributor.author | Kigen, Gabriel | - |
dc.date.accessioned | 2021-08-10T09:09:40Z | - |
dc.date.available | 2021-08-10T09:09:40Z | - |
dc.date.issued | 2017 | - |
dc.identifier.uri | https://www.ajol.info/index.php/pamj/article/view/159918 | - |
dc.identifier.uri | http://ir.mu.ac.ke:8080/jspui/handle/123456789/4998 | - |
dc.description.abstract | The use of the antiretroviral drug tenofovir has been associated with nephrotoxicity. However, the overall impact of this adverse effect has not been comprehensively evaluated. Some researchers have reported that it is quite severe to warrant monitoring for renal toxicity, while others have concluded that the magnitude may not be that significant. We report two clinical cases seen in our renal clinic with high creatinine levels suggestive of nephrotoxicity who reverted back to normality upon withdrawal of tenofovir. | en_US |
dc.language.iso | en | en_US |
dc.publisher | AJOL | en_US |
dc.subject | HIV/AIDS | en_US |
dc.subject | Nephrotoxicity | en_US |
dc.subject | Tenofovir | en_US |
dc.title | Reversal of tenofovir induced nephrotoxicity: case reports of two patients | en_US |
dc.type | Article | en_US |
Appears in Collections: | School of Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.